Department of Pathology, Wake Forest School of Medicine.
Department of Pathology, UNC School of Medicine, Chapel Hill, NC.
Appl Immunohistochem Mol Morphol. 2024 Sep 1;32(8):382-388. doi: 10.1097/PAI.0000000000001214. Epub 2024 Jul 11.
Merkel cell carcinoma (MCC) is a rare, highly aggressive skin cancer of neuroendocrine origin that is typically associated with either the presence of Merkel cell polyomavirus or chronic exposure to ultraviolet (UV) light. We report a case of relapsed MCC that presented with new symptoms of fatigue, back pain, and myeloid left shift identified during scheduled follow-up. The patient was found to have circulating neoplastic cells in the peripheral blood and bone marrow metastasis. Immunohistochemistry for synaptophysin, CD56, INSM-1, CK20, CD117 were positive, whereas CD34, TdT, Chromogranin, CD10, myeloperoxidase, CD3 and CD19 were negative. Flow cytometry of the peripheral blood confirmed the presence of an abnormal nonhematopoietic cell population expressing CD56 positivity. A next-generation sequencing (NGS) panel revealed the presence of variants in RB1, TP53, and other genes, some of which have not been previously described in MCC. This rare presentation highlights the challenges in the diagnosis and management of MCC.
默克尔细胞癌(Merkel cell carcinoma,MCC)是一种罕见的、高度侵袭性的皮肤神经内分泌癌,通常与 Merkel 细胞多瘤病毒的存在或慢性暴露于紫外线(UV)有关。我们报告了一例复发性 MCC 病例,该病例在定期随访中出现新的疲劳、背痛和骨髓左移等症状。患者外周血中有循环肿瘤细胞,并发生骨髓转移。免疫组化检测突触素、CD56、INSM-1、CK20、CD117 阳性,而 CD34、TdT、嗜铬粒蛋白、CD10、髓过氧化物酶、CD3 和 CD19 阴性。外周血流式细胞术证实存在异常的非造血细胞群体,表达 CD56 阳性。下一代测序(next-generation sequencing,NGS)面板显示 RB1、TP53 及其他基因存在变异,其中一些变异在 MCC 中尚未被描述过。这种罕见的表现强调了 MCC 的诊断和管理所面临的挑战。